These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27161753)

  • 41. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
    Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
    Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic effect of direct hemoperfusion with a polymyxin B-immobilized fiber column in the treatment of HIV-negative severe pneumocystis pneumonia.
    Tachikawa R; Tomii K; Murase K; Ueda H; Harada Y; Kida Y; Ishihara K
    Respiration; 2011; 81(4):318-24. PubMed ID: 20530959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human pneumocystosis.
    Singhal R; Mirdha BR; Guleria R
    Indian J Chest Dis Allied Sci; 2005; 47(4):273-83. PubMed ID: 16255399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pneumocystis: epidemiology and molecular approaches].
    Jarboui MA; Mseddi F; Sellami H; Sellami A; Makni F; Ayadi A
    Pathol Biol (Paris); 2013 Dec; 61(6):239-44. PubMed ID: 23849772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical Pearl: Pneumocystis pneumonia prophylaxis for patients on chronic systemic corticosteroids.
    Lemaire CM; Browning JC; Hsu S
    J Am Acad Dermatol; 2006 Jul; 55(1):124-5. PubMed ID: 16781304
    [No Abstract]   [Full Text] [Related]  

  • 46. Diagnostic approach of pulmonary disease in the HIV negative immunocompromised host.
    Safadi AR; Soubani AO
    Eur J Intern Med; 2009 May; 20(3):268-79. PubMed ID: 19393494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
    Caiaffa WT; Vlahov D; Graham NM; Astemborski J; Solomon L; Nelson KE; Muñoz A
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1493-8. PubMed ID: 7952605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concurrent infection of pneumocystis pneumonia and pulmonary tuberculosis in an HIV-seronegative patient.
    Janmeja AK; Mohapatra PR; Shivaprakash MR; Khurana A; Aggarwal D
    Indian J Chest Dis Allied Sci; 2008; 50(4):369-71. PubMed ID: 19035059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions.
    Lehman JS; Kalaaji AN
    J Am Acad Dermatol; 2010 Nov; 63(5):815-23. PubMed ID: 20643496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of severe pneumocystis pneumonia with clindamycin-primaquine in an HIV-negative patient.
    Crisp HC; Stewart IJ; Blatz PJ; Rice DH; Okulicz JF
    South Med J; 2009 Nov; 102(11):1161-3. PubMed ID: 19864989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pneumocystis carinii pneumonia].
    Nakamura T
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():576-80. PubMed ID: 12722283
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pneumocystis pneumonia in patients with steroid-dependent asthma].
    Dziedziczko A; Banach-Wawrzeńczyk E
    Pneumonol Alergol Pol; 1997; 65(5-6):399-405. PubMed ID: 9340071
    [No Abstract]   [Full Text] [Related]  

  • 53. The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus.
    LaRocque RC; Katz JT; Perruzzi P; Baden LR
    Clin Infect Dis; 2003 Nov; 37(10):1380-3. PubMed ID: 14583873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pneumocystis carinii pneumonia in HIV-negative immunosuppressed patients].
    Speich R; Hohl M; Hess T; Russi EW
    Schweiz Med Wochenschr; 1992 Jan; 122(3):45-54. PubMed ID: 1733012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pneumocystosis as a nosocomial infection].
    Meĭmorian MA
    Med Parazitol (Mosk); 2015; (1):33-5. PubMed ID: 25850313
    [No Abstract]   [Full Text] [Related]  

  • 56. Quantification of the effect of chemotherapy and steroids on risk of Pneumocystis jiroveci among hospitalized patients with adult T-cell leukaemia.
    Maeda T; Babazono A; Nishi T; Matsuda S; Fushimi K; Fujimori K
    Br J Haematol; 2015 Feb; 168(4):501-6. PubMed ID: 25266912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pneumocystosis pneumonia in immunocompromised patients.
    Joob B; Wiwanitkit V
    Pulmonology; 2020; 26(6):418. PubMed ID: 31744754
    [No Abstract]   [Full Text] [Related]  

  • 58. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals.
    Li MC; Lee NY; Lee CC; Lee HC; Chang CM; Ko WC
    J Microbiol Immunol Infect; 2014 Feb; 47(1):42-7. PubMed ID: 23063081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pneumocystosis. Current concepts and recent advances.
    Salfelder K; Venezuela M; Schwarz J
    Am J Dis Child; 1967 Dec; 114(6):693-9. PubMed ID: 4862686
    [No Abstract]   [Full Text] [Related]  

  • 60. Respiratory illness in HIV-negative immunocompromised patients.
    Tietjen PA; White DA
    Curr Opin Pulm Med; 1997 Mar; 3(2):125-30. PubMed ID: 9193858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.